Cargando…

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?

The reason why dopamine neurons die in Parkinson’s disease remains largely unknown. Emerging evidence points to a role for brain inflammation in neurodegeneration. Essential questions are whether brain inflammation happens sufficiently early so that interfering with this process can be expected to s...

Descripción completa

Detalles Bibliográficos
Autor principal:	Gundersen, Vidar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946840/ https://www.ncbi.nlm.nih.gov/pubmed/33716638 http://dx.doi.org/10.3389/fnins.2020.580311

Ejemplares similares

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
por: Błaszczyk, Janusz W.
Publicado: (2018)

Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
por: Li, Xiang, et al.
Publicado: (2021)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Erratum: The promise of neuroprotective agents in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2013)

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
por: Wang, Li-Yuan, et al.
Publicado: (2019)

Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
por: Curry, Daniel W., et al.
Publicado: (2018)

Gene Therapy: A Promising Approach for Neuroprotection in Parkinson’s Disease?
por: Valdés, Pamela, et al.
Publicado: (2016)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

Riboflavin Has Neuroprotective Potential: Focus on Parkinson’s Disease and Migraine
por: Marashly, Eyad T., et al.
Publicado: (2017)

From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
por: Mancini, Andrea, et al.
Publicado: (2020)

Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease
por: Liu, Mei-Fang, et al.
Publicado: (2018)

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease
por: Chen, Tian-Jiao, et al.
Publicado: (2020)

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
por: Reich, Niklas, et al.
Publicado: (2022)

Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
por: Yang, Qianwen, et al.
Publicado: (2019)

c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease
por: Lindholm, Dan, et al.
Publicado: (2016)

Commentary: Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?
por: Segura-Aguilar, Juan
Publicado: (2017)

Voltage-Gated Ca(2+) Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson's Disease?
por: Ortner, Nadine J.
Publicado: (2021)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson’s Disease
por: Kuwahara, Ken, et al.
Publicado: (2020)

Inflammation in Parkinson’s disease: role of glucocorticoids
por: Herrero, María-Trinidad, et al.
Publicado: (2015)

Neuroprotective and Neurorestorative Effects of Holothuria scabra Extract in the MPTP/MPP(+)-Induced Mouse and Cellular Models of Parkinson’s Disease
por: Noonong, Kunwadee, et al.
Publicado: (2020)

Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
por: Gómez-Soler, Maricel, et al.
Publicado: (2018)

Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment
por: Eker, Furkan, et al.
Publicado: (2023)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease
por: Esteves, Marta, et al.
Publicado: (2015)

Chronic Inflammation Links Cancer and Parkinson’s Disease
por: Li, Zhiming, et al.
Publicado: (2016)

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
por: Chen, Qian-Qian, et al.
Publicado: (2019)

Strategies for Study of Neuroprotection from Cold-preconditioning
por: Mitchell, Heidi M., et al.
Publicado: (2010)

Mitochondrial Preconditioning: A Potential Neuroprotective Strategy
por: Correia, Sónia C., et al.
Publicado: (2010)

Ginseng: a promising neuroprotective strategy in stroke
por: Rastogi, Vaibhav, et al.
Publicado: (2015)

From the bench to the bedside: Emerging science in Parkinson’s disease, cholesterol metabolism, and neuroprotection
por: Hauptman, Jason S.
Publicado: (2010)

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2(WD40) Genetic Model of Parkinson’s Disease
por: Casu, Maria Antonietta, et al.
Publicado: (2020)

Dose-Dependent Neuroprotective Effect of Standardized Bee Venom Phospholipase A(2) Against MPTP-Induced Parkinson’s Disease in Mice
por: Kim, Kyung Hwa, et al.
Publicado: (2019)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
por: Sarkar, Sumit, et al.
Publicado: (2016)

Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
por: Torres, Napoleon, et al.
Publicado: (2017)

Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation
por: Koudriavtseva, Tatiana, et al.
Publicado: (2016)

Targeting the inflammasome in Parkinson’s disease
por: Su, Qi, et al.
Publicado: (2022)

Age-Related Midbrain Inflammation and Senescence in Parkinson’s Disease
por: Russo, Taylor, et al.
Publicado: (2022)

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
por: Iarkov, Alexandre, et al.
Publicado: (2020)

The Wnt/β-catenin signaling: a multifunctional target for neuroprotective and regenerative strategies in Parkinson’s disease
por: Serafino, Annalucia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vodvimbvkgtueo6lu9lpu2bhu2